Abstract
Sensorineural hearing loss is an infrequently recognized side effect of pain medication abuse. Chronic pain patients treated with opiates develop different degrees of tolerance to pain medications. In many cases, the tolerance becomes the gateway to a variety of cycles of overuse and unmasking of significant psychiatric morbidity and mortality. An individualized approach utilizing combined treatment modalities (including nonopiate pharmaceuticals) is expected to become the norm. Patients can now be provided with multidisciplinary care that addresses an individual’s psychiatric, social, and medical needs, which requires close cooperation between physicians of varying specialties. This report describes a patient who experienced hearing loss from hydrocodone/acetaminophen abuse.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 357 |
| Number of pages | 1 |
| Journal | Primary Care Companion to the Journal of Clinical Psychiatry |
| Volume | 17 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2015 |
Fingerprint
ASJC Scopus subject areas
- Psychiatry and Mental health
Cite this
Implications of sensorineural hearing loss with hydrocodone/acetaminophen abuse. / Novac, Andrei; Iosif, Ana-Maria; Groysman, Regina; Bota, Robert G.
In: Primary Care Companion to the Journal of Clinical Psychiatry, Vol. 17, No. 5, 2015, p. 357.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Implications of sensorineural hearing loss with hydrocodone/acetaminophen abuse
AU - Novac, Andrei
AU - Iosif, Ana-Maria
AU - Groysman, Regina
AU - Bota, Robert G.
PY - 2015
Y1 - 2015
N2 - Sensorineural hearing loss is an infrequently recognized side effect of pain medication abuse. Chronic pain patients treated with opiates develop different degrees of tolerance to pain medications. In many cases, the tolerance becomes the gateway to a variety of cycles of overuse and unmasking of significant psychiatric morbidity and mortality. An individualized approach utilizing combined treatment modalities (including nonopiate pharmaceuticals) is expected to become the norm. Patients can now be provided with multidisciplinary care that addresses an individual’s psychiatric, social, and medical needs, which requires close cooperation between physicians of varying specialties. This report describes a patient who experienced hearing loss from hydrocodone/acetaminophen abuse.
AB - Sensorineural hearing loss is an infrequently recognized side effect of pain medication abuse. Chronic pain patients treated with opiates develop different degrees of tolerance to pain medications. In many cases, the tolerance becomes the gateway to a variety of cycles of overuse and unmasking of significant psychiatric morbidity and mortality. An individualized approach utilizing combined treatment modalities (including nonopiate pharmaceuticals) is expected to become the norm. Patients can now be provided with multidisciplinary care that addresses an individual’s psychiatric, social, and medical needs, which requires close cooperation between physicians of varying specialties. This report describes a patient who experienced hearing loss from hydrocodone/acetaminophen abuse.
UR - http://www.scopus.com/inward/record.url?scp=84946566017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946566017&partnerID=8YFLogxK
U2 - 10.4088/PCC.15br01809
DO - 10.4088/PCC.15br01809
M3 - Article
AN - SCOPUS:84946566017
VL - 17
SP - 357
JO - The primary care companion for CNS disorders
JF - The primary care companion for CNS disorders
SN - 1523-5998
IS - 5
ER -